Skip to main content
. 2023 Jan 30;145(5):3075–3083. doi: 10.1021/jacs.2c11969

Figure 1.

Figure 1

(A) Scheme of covalent HaloTag7 labeling with a fluorescent ligand. (B) Structure of silicon rhodamine (SiR) modified with chloroalkane (SiR-CA = SiR-Halo35). (C) Scheme of non-covalent HaloTag7 labeling with a fluorescent exchangeable HaloTag Ligand (xHTL). (D) Structure of SiR-xHTLs consisting of methylsulfonamide (S5) or trifluoromethylsulfonamide (T5) ligands attached to the rhodamine.